22
Participants
Start Date
May 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Ticagrelor
90 mg oral immediate release tablets, single dose on days 1 and 9
Venlaflaxin
37.5 mg oral immediate release tablets, administered twice daily on days 4-8
Research Site, Overland Park
Research Site, Uppsala
Lead Sponsor
AstraZeneca
INDUSTRY